摘要
目的：分析曲伏前列素在复合小梁切除术后眼压控制不良患者中的应用价值。方法选取2011年1月～2013年12月在我院接受治疗的20例行复合小梁切除术的青光眼患者，术后均存在眼压控制不良情况，使用曲伏前列素滴眼液控制眼压，观察治疗后效果。结果20例患者眼压控制总有效率达到70.0%，随访中，无一例发生视力下降、杯盘比增大、视神经纤维变薄等，且用药过程均无药物相关不良反应。结论曲伏前列素用于复合小梁切除术后眼压控制不良治疗中，可有效降低眼压，避免视神经功能的进一步损害。
Objective To analysis the application value of the patients with the negative pressure controlled by the patients with the compound trabeculectomy after the trabeculectomy. Methods Selected 20 cases of complex trabeculectomy poor control after glaucoma from January 2011 to December 2013 in our hospital, used the forefront of travoprost hormone eye drops in the control of intraocular pressure, and observed the treatment effect. Results 20 cases of intraocular pressure control the total efifciency reaches 70.0%, follow-up in all patients, there were no decreased visual acuity, cups and saucers ratio increases and the optic nerve fiber further thin phenomenon, and drug related adverse reaction occurred in one case no course of treatment. Conclusion The forefront of travoprost＆amp;nbsp;for the compound trabeculectomy with poorly controlled trabeculectomy poor control after treatment in, can reduce trabeculectomy poor control effectively and avoid further damage of nerve function.
出处
《中国继续医学教育》
2015年第19期159-160,共2页
China Continuing Medical Education
